about
Behcet's disease: epidemiology, clinical manifestations, and diagnosis.Recent epidemiological data on Behçet's disease in Iran. The 2001 survey.Gluten sensitivity enteropathy in patients with recurrent aphthous stomatitis.Development of a questionnaire for identification of the risk factors for osteoarthritis of the knees in developing countries. A pilot study in Iran and Bangladesh. An ILAR-COPCORD phase III study.Behcet's disease: from East to West.Estimating the prevalence and disease characteristics of rheumatoid arthritis in Tehran: A WHO -ILAR COPCORD Study (from Iran COPCORD study, Urban Study stage 1).The perspectives of Iranian physicians and patients towards patient decision aids: a qualitative study.Development of rheumatology in Tehran University of Medical Sciences.Characterization of the major histocompatibility complex locus association with Behçet's disease in Iran.Fc-Gamma Receptor 3B Copy Number Variation Is Not a Risk Factor for Behçet's Disease.Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian.Ophthalmic findings in Behcet׳s disease: Cases without apparent ocular signs.Vitamin D deficiency in patients with Behcet's diseaseInvestigation of bacterial and viral agents and immune status in Behcet's disease patients from Iran.Osteoarthritis of the knees in the COPCORD world.Quality-of-life measurement in blistering diseases.A time for action: Opportunities for preventing the growing burden and disability from musculoskeletal conditions in low- and middle-income countries.The saga of diagnostic/classification criteria in Behcet's disease.Diagnosis/Classification Criteria for Behcet's Disease.Brief report: association of CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 With Behçet's disease in Iranians.Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients.FUT2: filling the gap between genes and environment in Behçet's disease?The prevalence of oral aphthosis in a normal population in Iran: a WHO-ILAR COPCORD study.WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran.Effect of ethnic origin (Caucasians versus Turks) on the prevalence of rheumatic diseases: a WHO-ILAR COPCORD urban study in Iran.Prevalence of musculoskeletal disorders in southeastern Iran: a WHO-ILAR COPCORD study (stage 1, urban study).WHO-ILAR COPCORD study (stage 1, urban study) in Sanandaj, Iran.Prevalence of osteoarthritis in rural areas of Iran: a WHO-ILAR COPCORD study.Epidemiology of rheumatic diseases in Iran from analysis of four COPCORD studies.Are daily physical activities risk factors for knee osteoarthritis?Prospective study of articular manifestations in Behçet's disease: five-year report.On the genetics of the Silk Route: association analysis of HLA, IL10, and IL23R-IL12RB2 regions with Behçet's disease in an Iranian population.Adult Behcet's disease in Iran: analysis of 6075 patients.Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study.Pathological and Immunological Developments in Behcet's Disease.Re-evaluation of heterogeneity in HLA-B*510101 associated with Behçet's disease.Behcet's disease in Iran: analysis of 6500 cases.Pimecrolimus versus placebo in genital aphthous ulcers of Behcet's disease: a randomized double-blind controlled trial.Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).How to deal with Behcet's disease in daily practice.
P50
Q30249286-39AFD831-B152-4510-A4CA-980667E8B7E5Q30818473-B0C31EB1-514F-4033-8D29-61E6A6BCEB64Q33469936-337C1314-648D-4857-969E-329868C9D879Q33655507-59880EA9-11B4-435E-99A1-90B909CB85C2Q34107584-41728385-51F2-4916-860C-2F928521B25CQ34992923-F0902441-8F7F-42EF-B278-E2CFE031998BQ34997676-ABC90C66-DA44-43CF-BAA0-61689F9D17F6Q35010546-720CBBC7-9839-479B-977C-9D9214404F87Q35555973-19CE4E46-9196-4169-9699-0A2B8E35CDF5Q36014406-474C6601-1983-41B1-A451-9C48F16E5E3DQ36864026-1EFAEFE0-7045-4FE5-BBB0-0E15468574E3Q36928949-E99979E7-816E-41C9-824A-E5D6CA684641Q37717574-7DE0BCC1-B28C-46DF-908A-43E9F6819DB9Q37850448-EC42BF3D-AE39-4878-82DA-CEF0FF0F9464Q37868772-F0769BD4-2B07-4A75-ACCF-115FAEC59A69Q37979353-2584B6DF-2B85-48BD-B5BB-702F819A0AE7Q38284135-3A321A6F-4C50-44B6-BB9D-13D157DBCE13Q38423557-23D4AB6D-80B2-4DAD-9E59-47784940DB6BQ38569440-64DB2875-EA20-4896-92CD-B6E739324111Q38993169-A9C8CA37-652B-4FC8-9900-CB79AEE5839EQ39004832-F29540EA-3E88-416F-9E01-819F3A221254Q39606833-A55E3374-C7FE-4EE0-91F1-FC3E17E8E53BQ39836309-F7E78155-0C88-4EFA-8658-7995A0BA455EQ39845669-020E2318-DAA1-4985-A977-3D9791060A28Q39894474-392EB466-311B-4560-8CFA-97BD7DBC9845Q40146221-68CF3661-88BB-45F2-8081-D20492975105Q40149130-E4B15831-7106-47DF-891B-E65665199D44Q40176797-62B440CD-4A22-4234-8CAC-3E650CD3856DQ40259992-645892A9-64C6-456B-8068-914623FC7DB0Q40708305-E83ED421-EB15-47A2-8C2D-B89DF03FD335Q40797459-F8A82D95-9A23-443E-8F5A-7C99B9478B66Q40977749-DDA05B08-E457-4D48-9345-F76FE0DB7085Q41498417-AE3DAFBE-A547-46DF-BDBF-1101C24F6992Q41663457-2BE6715A-5560-4C1F-B032-0F2FEB102340Q41900541-5057F68E-AB5F-43DD-8EA5-E38B88DB776FQ42594547-08FFCA4B-0485-4BE8-A2A7-22E55AE52983Q42768402-F3A302F5-313B-4730-BE3D-F0B50C85F3F0Q42939552-12012BE3-A02E-4FF5-AE60-68A580349D46Q42939553-FCE66F3B-CEFF-4694-9E79-CB56A375D9D1Q43034711-25E3383E-6DB1-4DF9-AD0C-9C804BC5251A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fereydoun Davatchi
@ast
Fereydoun Davatchi
@en
Fereydoun Davatchi
@es
Fereydoun Davatchi
@nl
Fereydoun Davatchi
@sl
type
label
Fereydoun Davatchi
@ast
Fereydoun Davatchi
@en
Fereydoun Davatchi
@es
Fereydoun Davatchi
@nl
Fereydoun Davatchi
@sl
prefLabel
Fereydoun Davatchi
@ast
Fereydoun Davatchi
@en
Fereydoun Davatchi
@es
Fereydoun Davatchi
@nl
Fereydoun Davatchi
@sl
P1053
L-9490-2016
P106
P1153
7003558342
P2798
P31
P3829
P496
0000-0003-0508-7013